期刊文献+

胎儿宫内发育迟缓疾病标志物的初步研究 被引量:1

Preliminary Study of Differential Proteins of Intrauterine Growth Retardation
原文传递
导出
摘要 目的筛选胎儿宫内发育迟缓大鼠血清中差异表达的蛋白质,寻找与胎儿宫内发育迟缓相关的疾病标志物。方法收集大鼠疾病正常组、IUGR组血浆各3例;TCA法沉淀血清蛋白,建立疾病组和正常组蛋白质的双向凝胶电泳图谱;Image Master分析软件分析差异蛋白质;飞行时间质谱(MALDI-TOF-MS)获得差异蛋白肽指纹图谱,MASCOT引擎搜索蛋白质种类。结果鉴定出个差异蛋白点3个,分别为:IGF-Ⅰ、IGF-Ⅱ、IGFBP-3。结论 IGF-Ⅰ、IGF-Ⅱ、IGFBP-3,可能是胎儿宫内发育迟缓疾病诊断的生物标志物。 Objective Differential serum proteins of rat with Intrauterine Growth Retardation were identifieated with proteomies teehnology ,and associated disease markers of intrauterine growth retardation were found. Method 3 cases rats plasma of normal group and IUGR group were collected, respectively. After serum proteins were extracted with TCA precipitation method ,We established proteins Image of two-dimensional gel electrophoresis of IUGR group and normal grotip. Differential proteins were screened with Image Master software, and peptide mass finger- printing were obtained by MALDI-TOF-MS, then dstabase were searched through the Mascot data engine, and protein identification results were obtained. Results 3 differential protein spots were identificatied. Conclusion IGF- I , IGF- I1,IGFBP-3 are possible bio-markers of In- trauterine Growth Retardation diagnosis.
出处 《世界科技研究与发展》 CSCD 2013年第6期736-738,共3页 World Sci-Tech R&D
基金 重庆市卫生局课题(2009-2-225)资助
关键词 胎儿宫内发育迟缓 血浆 双向凝胶电泳 蛋白质组学 飞行时间质谱 IUGR ( intrauterine growth retardation) plasma 2-D gel electrophoresis proteomics MALDI-TOF-MS
  • 相关文献

参考文献11

二级参考文献42

  • 1张静,田鸾英,高武红,陈实.瘦素及瘦素受体与胎儿生长受限的关系[J].中华围产医学杂志,2004,7(6):327-330. 被引量:3
  • 2冯景,周有利,张吉才,陶建蜀.甲基化特异性PCR全程易出现的问题与控制措施[J].检验医学,2006,21(4):437-438. 被引量:4
  • 3顾婷婷,张忠明,郑鹏生.DNA甲基化研究方法的回顾与评价[J].中国妇幼健康研究,2006,17(6):555-560. 被引量:25
  • 4Mamelle N, Bonid M, Rivire O, Joly MO, Mellier G, Maria B, et al. Identification of newborns with fetal growth restriction (FGR) in weight and/or length based on constitutional growth potential[J]. Eur J Pediatr, 2006, 165( 10): 717-725.
  • 5Bos AF, Einspieler C, Prechtl HF. Intrauterine growth retardation, general movements, and neurodevelopmental outcome: a review[J]. Dev Med Child Neurol, 2001,43(1) :61-68.
  • 6Lorente A, Mueller W, Urdangarin E, Lazcoz P, yon Deimling A, Castresana JS. Detection of methylation in promoter seguences by melting curve analysis-based semiguantitative real time PCR [ J ]. BMC Cancer, 2008, 8: 61.
  • 7Turner CL, Mackay DM, Callaway JL, Docherty LE, Poole RL, Bullman H, et al. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted Ioci[J]. Eur J Hum Genet, 2010, 18(6) :648-655.
  • 8Paquette J, Bessette B, Ledru E, Deal C. Identification of up-stream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin [ J ]. Endocrinology, 2007, 148(12) :6007-6018.
  • 9Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, et al. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phe- notype, and p53[J]. Neoplasia, 2007, 9(12) : 1091-1098.
  • 10Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development[J]. Proc Natl Acad Sci U S A, 2007, 104(32) : 13056-13061.

共引文献6

同被引文献15

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部